Alcon Gains FDA Approval for Novel DED Drug episode artwork

EPISODE · Jun 4, 2025 · 8 MIN

Alcon Gains FDA Approval for Novel DED Drug

from Eyewire News: The Podcast · host Eyewire News

Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment in their respective phase 3 trials.  Learn more about your ad choices. Visit megaphone.fm/adchoices

NOW PLAYING

Alcon Gains FDA Approval for Novel DED Drug

0:00 8:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Eyewire News: The Podcast?

This episode is 8 minutes long.

When was this Eyewire News: The Podcast episode published?

This episode was published on June 4, 2025.

What is this episode about?

Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment...

Can I download this Eyewire News: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!